Committed to making innovative therapeutic ideas

accessible to patients – driven by patient need,

independent of commercial potential

Who we are

ReMedys is a not-for-profit entity, founded by biopharmaceutical industry professionals, to drive a novel, collaborative approach for translational research and development.


Become the preferred partner to bridge the gap between research and industrial partnering to give new therapeutic options and patients that need them a fair chance.


Ensure that promising therapeutic ideas, independent of their commercial potential, become available to patients in need.

Our Focus innovative therapeutic approaches for patients with severe disease without effective treatment. In partnership with academic research and industry experts we strive to secure for our projects the best possible transition from research to clinical proof-of-concept and on to the patients in need.

Amyotrophic Lateral Sclerosis

  • Amyotrophic Lateral Sclerosis

    ALS, also known as Lou Gehrig’s disease, is a rapidly progressive, fatal neurological disease,...

Diabetic Neuropathy


  • Parasite Induced Cancer

    Opisthorchis or liver flukes are parasitic flatworms that are ingested with incompletely cooked...